Compare AbCellera Biologics Inc (ABCL) vs Airbnb, Inc. (ABNB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Airbnb, Inc. — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Airbnb, Inc. trades at $142.23 (market cap $88.31B). The key difference: Airbnb, Inc. is far larger — about 37.6× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | ABNB | |
|---|---|---|
Market Cap | $2.35B | $88.31B |
Sector | Health | Consumer Cyclical |
52-Week High | $8.12 | $148.93 |
52-Week Low | $2.78 | $111.54 |
Enterprise Value | $1.99B | $78.84B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Airbnb, Inc.
Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.
Read more on ABNB →
